Company intelligence
MadeAi
Accelerating evidence synthesis with AI you can trust
About MadeAi
MadeAi™, developed by CapeStart, is an AI platform that streamlines life sciences evidence synthesis workflows. Its flagship solution, MadeAi-LR, accelerates literature reviews by up to 60% while maintaining over 90% accuracy. MadeAi enables additional evidence synthesis workflows including GVDs, MIRs, CERs, and JCA assistance, among others. The platform combines advanced machine learning with human validation to ensure FDA and EMA compliance. MadeAi is headquartered in Cambridge, Massachusetts and supported by CapeStart’s global team of 600+ professionals.
Verified activity
Signals from MadeAi
9 published signals
Technology & Infrastructure
MadeAi validated its graph-inference capability across seven visual formats, achieving approximately 98% accuracy on graph and chart-inferred values with 99% traced to the exact figure and supporting source sentence.
Reported by MadeAi
Presence & Recognition
MadeAi is attending the BioTechX USA 2026 conference in Boston from September 29 to 30 at the Hynes Convention Center.
Reported by MadeAi
Research & Knowledge
MadeAi tested its graph-inference capability through expert validation, reviewing 7 chart and graph formats, 81 graph-inferred data points, and achieving approximately 98% accuracy.
Reported by MadeAi
Presence & Recognition
MadeAi won the 2026 Fierce AI Innovation Award for its new AI-assisted Risk of Bias feature.
Reported by MadeAi
Presence & Recognition
MadeAi received a Gold Stevie® Award for its new AI-assisted Risk of Bias feature.
Reported by MadeAi
Presence & Recognition
MadeAi is preparing for an exciting lineup of events across the evidence-generation community including an Upcoming HEOR evaluation webinar, ISPOR Boston, BioTechX USA, ISPOR Europe, and BioTechX USA.
Reported by MadeAi
Presence & Recognition
MadeAi won the 2026 Fierce AI Innovation Awards in the AI Innovation in Medical Affairs category.
Reported by MadeAi
Presence & Recognition
MadeAi won the 2026 Fierce AI Innovation Award in the AI Innovation in Medical Affairs category.
Reported by MadeAi
Presence & Recognition
MadeAi is hosting a live discussion with Seye A. of Roche, Manuel Cossio of Cytel, and Ramiro Gilardino, MD of Insights & Impact, moderated by Head of Product Angeline Babitha on September 23, 2026, to discuss AI-generated evidence evaluation.
Reported by MadeAi